ESC Premium Access

Will the technical improvements in atrial fibrillation ablation further improve the success of atrial fibrillation ablation.

Congress Presentation

About the speaker

Professor Gerhard Hindricks

Charite University Hospital, Berlin (Germany)
80 presentations

3 more presentations in this session

Effects of atrial fibrillation ablation in patients with stroke risk factors: the CABANA Trial.

Speaker: Doctor D. Packer (Rochester, US)


Effects of atrial fibrillation ablation in patients with lV dysfunction: the CASTE-AF trial.

Speaker: Professor J. Brachmann (Coburg, DE)


Critical appraisal of the CABANA and CASTLE-AF trials.

Speaker: Professor I. Van Gelder (Groningen, NL)


Access the full session

Is atrial fibrillation ablation a mature treatment to reduce morbi-mortality?

Speakers: Professor G. Hindricks, Doctor D. Packer, Professor J. Brachmann, Professor I. Van Gelder

About the event


ESC Congress 2018

7 November - 29 August 2018

Sessions Presentations

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb